基于上述机制，团队进一步探索免疫调节药物 IVIG 的治疗潜力。研究发现： IVIG 可显著减少心脏中炎症性巨噬细胞和 CD8+ T 细胞的数量，抑制 IFN-γ ...

Intravenous immunoglobulin (IVIG) is a type of medication used to treat people with immunodeficiencies, when the immune ...

In conclusion, we consider that the available data indicate that IVIg is not a lost cause for the therapy of MS 15,16, and that clinical trials are therefore warranted to determine if a ...

Grifols has announced positive results from its phase 2/3 clinical trial evaluating the efficacy and safety of intravenous ...

Grifols has shared positive results from its clinical trial evaluating the efficacy and safety of intravenous immunoglobulin to treat patients with PPS.

Topline data were announced from a phase 2/3 trial evaluating Flebogamma 5% DIF (immune globulin intravenous ) in patients with post-polio syndrome (PPS).

Cantor Fitzgerald分析师维持对ADMA Biologics（NASDAQ:ADMA）的"增持"评级和25.00美元的目标价，强调该生物制药公司一贯保守的收入指引随后不断上调的模式。该机构分析指出，ADMA历来超越其初始财务预测，这一点从2024年公司超出销售指引33%的表现可见一斑。

The Supreme Court has dismissed a Fundamental Rights (FR) petition filed by Saman Ratnayake, a former Additional Secretary to ...

ADMA continues to maintain momentum in 2025 after its stupendous performance in 2024. Strong demand for Asceniv should fuel growth.

With an ever increasing number of patients being treated with IVIg for a wide array of immune-mediated disease, it is important that passive antibody transfer is considered when unexpected ...